T1期乳腺癌前哨淋巴结转移的影响因素(4)
[13]Kondov B，Kondov G，Spirovski Z，et al.Prognostic factors on the positivity for metastases of the axillary lymph nodes from primary breast cancer[J].Pril(Makedon Akad Nauk Umet Odd Med Nauki)，2017，38(1)：81-90.
[14]Yoshihara E，Smeets A，Laenen A，et al.Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice[J].Breast，2013，22(3)：357-361.
[15]Fujii T，Yajima R，Morita H，et al.Impact of vascular invasion of a primary tumor as a strong risk factor for disease recurrence in patients with node-positive breast cancer[J].Am Surg，2015，81(5)：523-526.
[16]吳爽，孙晓，丛斌斌，等.乳腺癌前哨淋巴结活检示踪剂研究进展[J].中国癌症杂志，2019，29(7)：540-544.
[17]Giuliano AE，Hunt KK，Ballman KV，et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis： a randomized clinical trial[J].JAMA，2011，305(6)：569-575.
[18]Giuliano AE，Ballman K，McCall L，et al.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases：long-term follow-up from the American College of Surgeons Oncology Group(Alliance)ACOSOG Z0011 randomized trial[J].Ann Surg，2016，264(3)：413-420.
(收稿日期：2019-09-23 本文编辑：任秀兰), 百拇医药(傅成斌 林舜国 许春森 韩晖)
[14]Yoshihara E，Smeets A，Laenen A，et al.Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice[J].Breast，2013，22(3)：357-361.
[15]Fujii T，Yajima R，Morita H，et al.Impact of vascular invasion of a primary tumor as a strong risk factor for disease recurrence in patients with node-positive breast cancer[J].Am Surg，2015，81(5)：523-526.
[16]吳爽，孙晓，丛斌斌，等.乳腺癌前哨淋巴结活检示踪剂研究进展[J].中国癌症杂志，2019，29(7)：540-544.
[17]Giuliano AE，Hunt KK，Ballman KV，et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis： a randomized clinical trial[J].JAMA，2011，305(6)：569-575.
[18]Giuliano AE，Ballman K，McCall L，et al.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases：long-term follow-up from the American College of Surgeons Oncology Group(Alliance)ACOSOG Z0011 randomized trial[J].Ann Surg，2016，264(3)：413-420.
(收稿日期：2019-09-23 本文编辑：任秀兰), 百拇医药(傅成斌 林舜国 许春森 韩晖)